91 results
Page 4 of 5
6-K
EX-99.1
nf7sz9i2vh mwet
7 Oct 22
Notice of date of Annual General Meeting
6:03am
6-K
EX-99.1
t48deqbcujcgp
19 Sep 22
Report of Foreign Private Issuer
9:38pm
6-K
EX-99.1
3ywg48dk7w
8 Sep 22
Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference
6:04am
6-K
EX-99.1
xfbnl0np
6 Sep 22
Incannex Included in the S&P/ASX 300 Index
6:01am
6-K
EX-99.1
seuu3wd
1 Sep 22
Report of Foreign Private Issuer
6:13am
6-K
EX-99.1
br7fllzi92r
17 Aug 22
Incannex Appoints FDA Regulatory Affairs Expert Mr Robert B. Clark to the Board of Directors
6:04am
6-K
EX-99.1
ek6lo3ns1lpuwpyt1
9 Aug 22
Report of Foreign Private Issuer
6:01am
6-K
EX-99.1
edu37
4 Aug 22
Report of Foreign Private Issuer
8:32pm
6-K
EX-99.1
rmrh 9lmc4qzyg
2 Aug 22
Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A
6:06am
6-K
EX-99.1
ev9dxo
21 Jul 22
Incannex Receives Ethics Approval to Commence Phase 1 Clinical Trial of Multi-Use Anti-Inflammatory Drug IHL-675A
6:02am
6-K
EX-99.2
28k hel1v6gn9k47p
28 Jun 22
Report of Foreign Private Issuer
6:52pm
6-K
EX-99.1
qmiy3ehl
28 Jun 22
Report of Foreign Private Issuer
6:52pm
6-K
EX-99.1
8sqp52o anbwj
3 Jun 22
Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea
6:02am
6-K
EX-99.1
7tfapb
16 May 22
Positive Pre-IND Meeting with US FDA for IHL-42X for Obstructive Sleep Apnoea
9:50pm
6-K
EX-99.3
ryibzs4so
12 May 22
Report of Foreign Private Issuer
9:25am
6-K
EX-99.2
5yoageto33mwole54t
12 May 22
Report of Foreign Private Issuer
9:25am
6-K
EX-99.1
anz1efi7 65gig3mke
12 May 22
Report of Foreign Private Issuer
9:25am
6-K
EX-99.2
bmhhwiqu
28 Apr 22
Quarterly Activities Report and Appendix 4C Cash Flow Statement
6:40am
6-K
EX-99.1
km2nrzs4
28 Apr 22
Quarterly Activities Report and Appendix 4C Cash Flow Statement
6:40am
6-K
EX-99.1
u3zczd07 m3xw
4 Apr 22
Incannex to Acquire APIRx Pharmaceuticals USA, LLC
6:07am